GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (XSWX:RO) » Definitions » Equity-to-Asset

Roche Holding AG (XSWX:RO) Equity-to-Asset

: 0.32 (As of Dec. 2023)
View and export this data going back to 2001. Start your Free Trial

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Roche Holding AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was CHF29,315 Mil. Roche Holding AG's Total Assets for the quarter that ended in Dec. 2023 was CHF90,468 Mil. Therefore, Roche Holding AG's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.32.

The historical rank and industry rank for Roche Holding AG's Equity-to-Asset or its related term are showing as below:

XSWX:RO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26   Med: 0.32   Max: 0.42
Current: 0.32

During the past 13 years, the highest Equity to Asset Ratio of Roche Holding AG was 0.42. The lowest was 0.26. And the median was 0.32.

XSWX:RO's Equity-to-Asset is ranked worse than
80.04% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs XSWX:RO: 0.32

Roche Holding AG Equity-to-Asset Historical Data

The historical data trend for Roche Holding AG's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.42 0.27 0.32 0.32

Roche Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.29 0.32 0.31 0.32

Competitive Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roche Holding AG Equity-to-Asset Distribution

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Equity-to-Asset falls into.



Roche Holding AG Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Roche Holding AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=29315/90468
=0.32

Roche Holding AG's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=29315/90468
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roche Holding AG  (XSWX:RO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Roche Holding AG Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Roche Holding AG (XSWX:RO) Business Description

Address
Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche Holding AG (XSWX:RO) Headlines

No Headlines